Publication: Serum IL-23 levels in patients with vitiligo
No Thumbnail Available
Date
2014-12-01T00:00:00Z
Authors
Cengiz, FATMA PELİN
Emiroglu, NAZAN
CEMIL, Bengu Cevirgen
ERDEM, Ummu Gul Bahar
KEMERIZ, Funda
Journal Title
Journal ISSN
Volume Title
Publisher
Metrics
Abstract
Background and Design: Interleukin-23 (IL-23) is a cytokine which is believed to have an important role in the pathogenesis of autoimmune diseases. Therefore, it can be used as a target molecule in the treatment of autoimmune diseases. The aim of our study was to determine serum IL-23 levels in patients with vitiligo to understand their possible roles in the disease etiology and to compare the results with the healthy controls.
Description
Keywords
Citation
Cengiz F. P. , Emiroglu N., CEMIL B. C. , ERDEM U. G. B. , KEMERIZ F., -Serum IL-23 levels in patients with vitiligo-, TURKDERM-ARCHIVES OF THE TURKISH DERMATOLOGY AND VENEROLOGY, cilt.48, ss.204-207, 2014